Close this search box.

Cannabis in Palliative Care: Exploring Benefits and Considerations

Session was held on December 15, 2023.

Explore the role of cannabis in palliative care during this informative webinar. Discover the research, clinical applications, and ethical insights surrounding cannabis use in end-of-life care. Learn about the potential benefits and challenges it presents to patients, caregivers, and health care professionals.


  • Craig Goldie, MD, CCFP(PC), FRCPC

Cannabis in Palliative Care: Exploring Benefits and Considerations

  • Vučković S et al. Cannabinoids and Pain: New Insights From Old Molecules. Frontiers in Pharmacology;2018(9):1259.
  • Maida V et al. Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. The Journal of Supportive Oncology. 2008 Mar;6(3):119-124. PMID: 18402303.
  • Johnson J et al. Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain. Journal of Pain and Symptom Management. 2010;39(2):167-179.
  • Portenoy R et al. Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial. The Journal of Pain. 2012;13(5):438-449.
  • Lichtman A et al. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain. Journal of Pain and Symptom Management. 2018;55(2):179-188.e1.
  • Kawka, M et al . Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom – analysis from the UK Medical Cannabis Registry. The Journal of Clinical Pharmacology. 2021; 00: 1- 10.
  • Ueberall M et al. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry. J Pain Res. 2019;12:1577-1604.
  1. Babson et al. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. J. Current Psychiatry Reports. 2017 Apr;19(4):23.
  2. Doremus et al. Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado. J. Complementary Therapies in Medicine. 2019 Dec;47.
  • Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473.
  • Allan G et al. Simplified guideline for prescribing medical cannabinoids in primary care. Can Fam Physician. 2018 Feb;64(2):111-120. PMID: 29449241; PMCID: PMC5964385.